Quick Links

Technologies for Licensing

McGill University has a rich history of scholarship and strong tradition of cutting edge research and innovation. McGill strives to translate the outcomes of its research endeavors in ways that have regional, national and global impact. McGill University maintains a comprehensive intellectual property portfolio.

You can view a selection of technologies that are available for licensing below:

Agriculture

   Plant Variety

            Currently not available

Biomedical

   Biomarkers

   Diagnostics and Instrumentation

            Screening assay for agents that induce Langerhans islet neogenesis in vitro (02198)
            Anatomical MRI Analysis Software for early detection and classification Neurological Diseases (04062)
            Maleimide-Terminated Water Soluble Monolayer-Protected-Gold-Nanoparticle (11040)
            Ultrasound System and methods for quantifying analytes and point of care diagnostics (06080)
            Ultrasound System for measuring pH and point of care parameters (09077)
            Rapid Malaria Detection (07116)
            Automatic identification and classification of Vestibulo-Ocular Responses (11045)
            Polymeric Systems for Signal Amplification in Gene Detection (05094)
            Microfluidic microarray for multiplex analysis of biomolecules (07084)

   Devices

   Surgical

Mechanical and Materials

Network Communications

Thereapeutic Agents

   Biologicals

            Cleaved Link N Usage for intervertebral disc repair(13081)
            Multitargeted kinase inhibitors that inhibit breast cancer progression (08082)
            Netrin Derivatives for inhibiting metastasis and neovascularization (10006)
            Single chain antibodies directed to pancreatic β cells (11021)
            DRR antisense reduces glioma invasiveness (10097)
            Antisense-based small RNA agents targeting GAG of HIV RNA (14064)
            Cell Permeable Peptide for Treatment of Allergic Airway Diseases (05003)
            Anti-Mitotic peptides for the treatment of cancer (04086)

            Netrin Derivatives for inhibiting metastasis and neovascularization (10006)
            Nucleic acid hairpins as inhibitors of HIV RNAse H (03050)
            Vaccine Adjuvant Platform (10084) 
           Single chain antibodies directed to pancreatic β cells (11021)

   Chemical Entities

   Drug Delivery

   Neutraceutical